Curriculum

CURRENT POSITION: Associate Professor academic discipline MED06/D3 Oncology, Department of Translational Medicine, Unife

QUALIFICATIONS

10/07/1995 Degree in Medical Doctor, Unime

10/1999 Board Certified in Hematology

10/2008 Board Certified in Oncology

2022 Master of Management for Medical Director

TEACHING ACTIVITY

Professor of Medical Oncology in the following Degree Courses as Medical School, Nursing (Ferrara, Pieve di Cento, Adria), Obstretics, Dietist, Sciences of Radiologist and Radiotherapy. Master's Degree in Nursing and Midwifery Sciences; Master's Degree in Researche metodologia and clinical research.

MANAGEMENT ACTIVITY

Director of Oncology Unit, University Hospital of Ferrara

Member of PhD in Advanced Therapies and Experimental Pharmacology, Unife

Member of the Graduate School of Oncology, Unife

Member of the International Association for the Study of Lung Cancer (IASCL) Since 2020 Member of the International Mesothelioma Interest Group (IMIG)
Member of Network officine terapie avanzate APS (NOTA)

Member of the European Society for Medical Oncology

RESEARCH ACTIVITY

Publications: 101 paper in international scientific journals, H Index=32, Citations=5204 (15 January 2025, Scopus) and 4 book chapters.

A total of approximately 150 presentations were presented as posters or oral communications at international and national Congresses.

Principal Investigator or Co-principal investigator of many tase I/II/III clinical trials.

Main Research Projects:

  • ISTITUTO TOSCANO TUMORI (ITT) – REGIONE TOSCANA GRANT PROPOSAL 2010- “Immunomonitoring of patients with advanced malignant mesothelioma treated with the anti-CTLA-4 monoclonal antibody tremelimumab. Study MESOT-TREM”-Durata 1 anno. Ruolo nel progetto: Princpal Investigator (finanziamento di 40 mila euro).
  • ASSOCIAZIONE ITALIANA PER LA RICERCA SUL CANCRO- Grant Proposal 2005 – PI Maio - Immunobiologic and clinical activity of DNA hypomethylating agents in human cutaneous melanoma. Durata 3 anni –Ruolo nel progetto: Collaborator
  • ISTITUTO TOSCANO TUMORI (ITT) – REGIONE TOSCANA GRANT PROPOSAL 2007 “Reprogramming of epigenetic patterns in human melanoma: immunotherapeutic implications”- Durata 3 anni- Ruolo nel progetto: Collaborator
  • ISTITUTO TOSCANO TUMORI (ITT) – REGIONE TOSCANA GRANT PROPOSAL 2013- “Immune checkpoints blockade as a novel immunotherapeutic strategy in malignant mesothelioma”-Durata 3 anni- Ruolo nel progetto: Collaborator
  • Ricerca Finalizzata 2016 – Progetti di rete –“Precision immunotherapy for cancer treatment: understanding resistance to therapy, improving patients selection, and designing novel therap eutic strategies”- Durata 3 anni- Ruolo nel progetto: Collaborator
  • ASSOCIAZIONE ITALIANA PER LA RICERCA SUL CANCRO - Grant Proposal 2005 “Immunobiologic and clinical activity of DNA hypomethylating agents in human cutaneous melanoma”- Durata 3 anni- Ruolo nel progetto: Collaborator
  • ASSOCIAZIONE ITALIANA PER LA RICERCA SUL CANCRO – Investigator Grant IG 2011 “Translating melanoma epigenetics in the clinical setting: molecular markers and comb bined chemoimmunotherapies”- Durata 3 anni- Ruolo nel progetto: Collaborator
  • ASSOCIAZIONE ITALIANA PER LA RICERCA SUL CANCRO – Investigator Grant IG 2014 “Exploring the therapeutic combination of epigenetic immunomodulation and immune checkpoint blockade in advanced melanoma”- Durata 3 anni- Ruolo nel progetto: Collaborator
  • Fondazione ASSOCIAZIONE ITALIANA PER LA RICERCA SUL CANCRO “Metastatic disease: the key unmet need in oncology” - 5 per Mille- 2017- Ruolo nel progetto: Principal Investigator Gruppo Leader Ferrara dal 2023 al 2025 (finanziamento di 204 mila euro)
  • Progetto PNRR-TR1-2023-12378111 “Longitudinal monItoring For the Earliest and BEst management for pLeural mesoThelioma (LIFEBELT)”, durata due anni. Ruolo nel progetto: Principal Investigator (finanziamento: 1 milione euro).